Autor: |
Bhatia B; Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA., Kechichian E; Department of Dermatology, CHU Henri Mondor, Créteil, France., Eleftheriadou V; Centre of Evidence Based Dermatology, Kings Meadow Campus, University of Nottingham, Nottingham, UK., Castelneau JP; Department of Dermatology, CHU Henri Mondor, Créteil, France., Seité S; La Roche-Posay Laboratoire Dermatologique, Paris, France., Meurant JM; Association Française du Vitiligo, Paris, France., Hamzavi I; Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA., Lim H; Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA., Seneschal J; Hôpital Saint-André, CHU Bordeaux, Bordeaux, France., Taieb C; EMMA, European Market Maintenance Assessment, Paris, France.; Santé Publique, Hôpital Necker, Paris, France., Ezzedine K; Department of Dermatology, CHU Henri Mondor, Créteil, France.; EA EpiDermE (Epidémiologie en Dermatologie et Evaluation des Thérapeutiques, UPEC UniversitéParis-Est Créteil), Créteil, France. |